* HealthStream Inc HSTM.OQ HSTM.O is expected to show a
rise
in quarterly revenue when it reports results on February 20.
* The Nashville Tennessee-based company is expected to
report a
5.7% increase in revenue to $68.009 million from $64.34 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data. The company's guidance on October 24
2022, for the period ended December 31, was for revenue of
$68.198 million.
* Refinitiv's mean analyst estimate for HealthStream Inc is
for
earnings of 5 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for
HealthStream Inc
is $29.5, above its last closing price of $24.63.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.05 0.05 0.12 Beat 130.8
Jun. 30 2022 0.05 0.05 0.10 Beat 117.4
Mar. 31 2022 0.02 0.03 0.09 Beat 221.4
Dec. 31 2021 0.02 0.01 0.05 Beat 316.7
Sep. -0.01 -0.01 0.05 Beat 600
30 2021
Jun. 30 2021 -0.03 -0.03 0.08 Beat 328.6
Mar. 31 2021 -0.07 -0.06 0.05 Beat 176.9
Dec. 31 2020 0.04 0.04 0.03 Missed -18.2
This summary was machine generated February 17 at 21:14 GMT.
All figures in US dollars unless otherwise stated